Follow us on Twitter

Tuesday 13 November 2012

BioCryst Pharmaceuticals completes Phase III influenza trial

http://www.equities.com/news/headline-story?dt=2012-11-12&val=698966&cat=hcare

Posted by Rob LW

No comments:

Post a Comment